Fotis Kalantzis

Fotis Kalantzis appears in our data through filings on Willow Biosciences Inc. shares, published by SEDI. Over a trading history stretching from 12 April 2019 to 28 April 2023, the count stands at 5 filings.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 1 May 2023, reports an option exercise of €575 in Willow Biosciences Inc. Typically, a trade is published a median of 3 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.